SMAR Daily Industry News

OpenAI acquires Orchestra Bio

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and advance new treatments.

Read more: https://openai.com/index/openai-to-acquire-orchest...